As AVMs in HHT require the combination of genetic deficiency in ENG/ALK1 signalling with an angiogenic trigger, there has been considerable interest in the role of VEGF, the “master” regulator of angiogenesis. This evidence concerns the gene ACVRL1 and hereditary hemorrhagic telangiectasia.